Twenty-five years ago, if Jeff Bezos had told me he would become the richest man on Earth while selling books from his garage, I would have laughed in disbelief. Yet here we are—his seemingly ...
Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...